Thyroid dysfunction in women with systemic sclerosis

Bianca Marasini, Pier Alda Ferrari, Nadia Solaro, Carlo Selmi

Research output: Chapter in Book/Report/Conference proceedingConference contribution

14 Citations (Scopus)

Abstract

Hypothyroidism has been frequently reported in systemic sclerosis (SSc), but whether SSc itself increases the risk of thyroid dysfunction is still controversial. The aim of the present study was to determine whether routine thyroid function screening in SSc should be warranted. Serum levels of free triiodothyronine, free thyroxine, and thyroid-stimulating hormone, and the presence of thyroid-specific autoantibodies (antithyroid peroxidase and antithyreoglobulin) were measured in 79 women with SSc and 81 age-matched women with osteoarthritis (OA) serving as controls. Hyperthyroidismwas found in 2 of 79 (2.5%) SSc and in 4 of 81 (5%) OA cases. Hypothyroidism was found in 16 of 79 (20%) patients with SSc (subclinical in 14/16 cases) and in 9 of 81 (11%) patients with OA (subclinical in all cases; P = 0.131). Antithyreoglobulin antibodies were present in 14% versus 13% patients (SSc versus OA, P = NS), whereas antithyroid peroxidase antibodies were present in 23% versus 11% patients (SSc versusOA, P = 0.057). The risk of hypothyroidism was significantly higher in antithyroid peroxidase-positive patients (P < 0.0001), irrespective of the primary diagnosis, and greater in women with OA (OR = 24.6, 95% CI 4.3-141.9, P < 0.0001) than SSc (OR = 4.2, 95% CI 1.2-14.3, P = 0.035). SSc is not independently associated with an increased risk of thyroid dysfunction, but antithyroid peroxidase antibodies may identify a subset of patients at risk of developing thyroid dysfunction.

Original languageEnglish (US)
Title of host publicationAnnals of the New York Academy of Sciences
Pages305-311
Number of pages7
Volume1108
DOIs
StatePublished - Jun 2007

Publication series

NameAnnals of the New York Academy of Sciences
Volume1108
ISSN (Print)00778923
ISSN (Electronic)17496632

Fingerprint

Systemic Scleroderma
Peroxidase
Thyroid Gland
Osteoarthritis
Antibodies
Hypothyroidism
Triiodothyronine
Thyrotropin
Set theory
Thyroxine
Autoantibodies
Screening

Keywords

  • Hypothyroidism
  • Scleroderma
  • Thyroid autoantibodies

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Marasini, B., Ferrari, P. A., Solaro, N., & Selmi, C. (2007). Thyroid dysfunction in women with systemic sclerosis. In Annals of the New York Academy of Sciences (Vol. 1108, pp. 305-311). (Annals of the New York Academy of Sciences; Vol. 1108). https://doi.org/10.1196/annals.1422.032

Thyroid dysfunction in women with systemic sclerosis. / Marasini, Bianca; Ferrari, Pier Alda; Solaro, Nadia; Selmi, Carlo.

Annals of the New York Academy of Sciences. Vol. 1108 2007. p. 305-311 (Annals of the New York Academy of Sciences; Vol. 1108).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Marasini, B, Ferrari, PA, Solaro, N & Selmi, C 2007, Thyroid dysfunction in women with systemic sclerosis. in Annals of the New York Academy of Sciences. vol. 1108, Annals of the New York Academy of Sciences, vol. 1108, pp. 305-311. https://doi.org/10.1196/annals.1422.032
Marasini B, Ferrari PA, Solaro N, Selmi C. Thyroid dysfunction in women with systemic sclerosis. In Annals of the New York Academy of Sciences. Vol. 1108. 2007. p. 305-311. (Annals of the New York Academy of Sciences). https://doi.org/10.1196/annals.1422.032
Marasini, Bianca ; Ferrari, Pier Alda ; Solaro, Nadia ; Selmi, Carlo. / Thyroid dysfunction in women with systemic sclerosis. Annals of the New York Academy of Sciences. Vol. 1108 2007. pp. 305-311 (Annals of the New York Academy of Sciences).
@inproceedings{bdf9626c060c4c90b0f697b9e2611899,
title = "Thyroid dysfunction in women with systemic sclerosis",
abstract = "Hypothyroidism has been frequently reported in systemic sclerosis (SSc), but whether SSc itself increases the risk of thyroid dysfunction is still controversial. The aim of the present study was to determine whether routine thyroid function screening in SSc should be warranted. Serum levels of free triiodothyronine, free thyroxine, and thyroid-stimulating hormone, and the presence of thyroid-specific autoantibodies (antithyroid peroxidase and antithyreoglobulin) were measured in 79 women with SSc and 81 age-matched women with osteoarthritis (OA) serving as controls. Hyperthyroidismwas found in 2 of 79 (2.5{\%}) SSc and in 4 of 81 (5{\%}) OA cases. Hypothyroidism was found in 16 of 79 (20{\%}) patients with SSc (subclinical in 14/16 cases) and in 9 of 81 (11{\%}) patients with OA (subclinical in all cases; P = 0.131). Antithyreoglobulin antibodies were present in 14{\%} versus 13{\%} patients (SSc versus OA, P = NS), whereas antithyroid peroxidase antibodies were present in 23{\%} versus 11{\%} patients (SSc versusOA, P = 0.057). The risk of hypothyroidism was significantly higher in antithyroid peroxidase-positive patients (P < 0.0001), irrespective of the primary diagnosis, and greater in women with OA (OR = 24.6, 95{\%} CI 4.3-141.9, P < 0.0001) than SSc (OR = 4.2, 95{\%} CI 1.2-14.3, P = 0.035). SSc is not independently associated with an increased risk of thyroid dysfunction, but antithyroid peroxidase antibodies may identify a subset of patients at risk of developing thyroid dysfunction.",
keywords = "Hypothyroidism, Scleroderma, Thyroid autoantibodies",
author = "Bianca Marasini and Ferrari, {Pier Alda} and Nadia Solaro and Carlo Selmi",
year = "2007",
month = "6",
doi = "10.1196/annals.1422.032",
language = "English (US)",
isbn = "157331708X",
volume = "1108",
series = "Annals of the New York Academy of Sciences",
pages = "305--311",
booktitle = "Annals of the New York Academy of Sciences",

}

TY - GEN

T1 - Thyroid dysfunction in women with systemic sclerosis

AU - Marasini, Bianca

AU - Ferrari, Pier Alda

AU - Solaro, Nadia

AU - Selmi, Carlo

PY - 2007/6

Y1 - 2007/6

N2 - Hypothyroidism has been frequently reported in systemic sclerosis (SSc), but whether SSc itself increases the risk of thyroid dysfunction is still controversial. The aim of the present study was to determine whether routine thyroid function screening in SSc should be warranted. Serum levels of free triiodothyronine, free thyroxine, and thyroid-stimulating hormone, and the presence of thyroid-specific autoantibodies (antithyroid peroxidase and antithyreoglobulin) were measured in 79 women with SSc and 81 age-matched women with osteoarthritis (OA) serving as controls. Hyperthyroidismwas found in 2 of 79 (2.5%) SSc and in 4 of 81 (5%) OA cases. Hypothyroidism was found in 16 of 79 (20%) patients with SSc (subclinical in 14/16 cases) and in 9 of 81 (11%) patients with OA (subclinical in all cases; P = 0.131). Antithyreoglobulin antibodies were present in 14% versus 13% patients (SSc versus OA, P = NS), whereas antithyroid peroxidase antibodies were present in 23% versus 11% patients (SSc versusOA, P = 0.057). The risk of hypothyroidism was significantly higher in antithyroid peroxidase-positive patients (P < 0.0001), irrespective of the primary diagnosis, and greater in women with OA (OR = 24.6, 95% CI 4.3-141.9, P < 0.0001) than SSc (OR = 4.2, 95% CI 1.2-14.3, P = 0.035). SSc is not independently associated with an increased risk of thyroid dysfunction, but antithyroid peroxidase antibodies may identify a subset of patients at risk of developing thyroid dysfunction.

AB - Hypothyroidism has been frequently reported in systemic sclerosis (SSc), but whether SSc itself increases the risk of thyroid dysfunction is still controversial. The aim of the present study was to determine whether routine thyroid function screening in SSc should be warranted. Serum levels of free triiodothyronine, free thyroxine, and thyroid-stimulating hormone, and the presence of thyroid-specific autoantibodies (antithyroid peroxidase and antithyreoglobulin) were measured in 79 women with SSc and 81 age-matched women with osteoarthritis (OA) serving as controls. Hyperthyroidismwas found in 2 of 79 (2.5%) SSc and in 4 of 81 (5%) OA cases. Hypothyroidism was found in 16 of 79 (20%) patients with SSc (subclinical in 14/16 cases) and in 9 of 81 (11%) patients with OA (subclinical in all cases; P = 0.131). Antithyreoglobulin antibodies were present in 14% versus 13% patients (SSc versus OA, P = NS), whereas antithyroid peroxidase antibodies were present in 23% versus 11% patients (SSc versusOA, P = 0.057). The risk of hypothyroidism was significantly higher in antithyroid peroxidase-positive patients (P < 0.0001), irrespective of the primary diagnosis, and greater in women with OA (OR = 24.6, 95% CI 4.3-141.9, P < 0.0001) than SSc (OR = 4.2, 95% CI 1.2-14.3, P = 0.035). SSc is not independently associated with an increased risk of thyroid dysfunction, but antithyroid peroxidase antibodies may identify a subset of patients at risk of developing thyroid dysfunction.

KW - Hypothyroidism

KW - Scleroderma

KW - Thyroid autoantibodies

UR - http://www.scopus.com/inward/record.url?scp=34948822277&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34948822277&partnerID=8YFLogxK

U2 - 10.1196/annals.1422.032

DO - 10.1196/annals.1422.032

M3 - Conference contribution

C2 - 17893994

AN - SCOPUS:34948822277

SN - 157331708X

SN - 9781573317085

VL - 1108

T3 - Annals of the New York Academy of Sciences

SP - 305

EP - 311

BT - Annals of the New York Academy of Sciences

ER -